Form EFFECT Adverum Biotechnologies,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312792 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- David Lowe Welcomes Missouri Lt. Governor David Wasinger During Pulaski County Visit
- Omni Bridgeway Makes Strong Start to FY27 with 3.9x MOIC on Completions and US$1 Billion Series II Final Close
- Labor & Employment Law Firm Zakay Law Group, APLC Files a Class Action Against It'Sugar Alleging Failure to Provide Meal and Rest Breaks
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share